首页> 美国卫生研究院文献>California Medicine >Diagnosing Pancreatic Cancer
【2h】

Diagnosing Pancreatic Cancer

机译:诊断胰腺癌

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The usefulness of a clinical examination was compared with several other procedures (ultrasonography, pancreatic function tests, endoscopic retrograde cholangiopancreatography and angiography) for diagnosing pancreatic cancer. We used a simplified form of decision analysis to show the effects of different strategies on direct diagnostic costs, missed diagnoses and false-positive diagnoses.Our analysis indicates that existing laboratory tests are either too non-specific or too invasive to be used successfully as screening tests for pancreatic cancer. To decrease the number of unnecessary laparotomies due to false-positive test findings, patients should have a high probability of pancreatic cancer, based on clinical criteria, before further testing is carried out. In fact, existing clinical criteria are both sensitive and specific for pancreatic cancer.
机译:将临床检查的有用性与其他几种诊断胰腺癌的方法(超声检查,胰腺功能检查,内镜逆行胰胆管造影和血管造影)进行了比较。我们使用简化的决策分析形式来展示不同策略对直接诊断成本,漏诊和误报诊断的影响。我们的分析表明,现有的实验室测试要么过于特异性,要么过于侵入性,无法成功地用于筛查胰腺癌检查。为了减少由于假阳性检查结果而导致的不必要的腹腔镜手术的数量,在进行进一步检查之前,根据临床标准,患者应具有很高的胰腺癌发生几率。实际上,现有的临床标准对胰腺癌既敏感又特异性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号